Binah Capital Group, Inc. BCG
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- -43.06%
- 1 year
- -29.61%
5D +0.64 (+54.70%)
- Market cap
- 27.98M
- Revenue (ttm)
- 161.90M
- Profit margin
- -1.82%
- EPS (ttm)
- 0.20
- Shares out
- 16.60M
- P/E ratio
- 8.20
- YTD return
- -43.06%
- 1-year return
- -29.61%
- Volume
- 224.01K
- Avg volume
- 38.42K
- Open
- 1.84
- Previous close
- 1.81
- Day's range
- 1.50 – 1.87
- 52-week range
- 0.991 – 3.11
- Beta
- 0.46
- 50-day average
- 2.55
Key statistics
- 200-day average
- 4.58
- Enterprise value
- 95.18M
- Price / sales
- 0.20
- Price / book
- 1.05
- Revenue growth
- 2.30%
- Total cash
- 6.63M
- Total debt
- 29.27M
- Return on equity
- -25.43%
- Short % of float
- 0.40%
Fundamental scorecard
7 of 25 checks passed on BCG’s reported financials
7of 25 checks passed
- Value 1 of 5
- Growth 2 of 5
- Profitability 3 of 5
- Financial health 1 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
About Binah Capital Group, Inc.
Binah Capital Group, Inc., together with its subsidiaries, operates in the wealth management industry. The company provides access to stock, bond, exchange-traded fund, and options execution services; and research, compliance, supervision, and accounting and related services for financial advisors. It also offers mutual funds and insurance products, as well as alternative investments, such as non-traded real estate investment trusts, unit trusts, and fixed and variable annuities. The company was founded in 2016 and is headquartered in Albany, New York. Binah Capital Group, Inc. operates as a subsidiary of MHC Securities, LLC.
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- United States
- Website
- wentworthms.com
News
12 Financials Stocks Moving In Friday's Pre-Market Session Binah Capital Group Q3 EPS $0.13 Up From $0.08 YoY, Sales $50.561M Beat $46.850M Estimate
Binah Capital Group Reports Results for Third Quarter of 2026
enGene to Initiate a BLA Submission for Detalimogene by Year End and Reports New Data from LEGEND Trial Pivotal Cohort 1 in BCG-Unresponsive NMIBC
IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial
Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer
Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential Symposium
FDA Expands ANKTIVA® Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease
Binah Capital Group, Inc. (NASDAQ:BCG) Stock Short Interest Report for September
Head-To-Head Comparison: Binah Capital Group (NASDAQ:BCG) versus Hennessy Advisors (NASDAQ:HNNA)
Your note
Sign in to keep a note on BCG — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MHC SECURITIES LLC | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Mar 14, 2024 | 9,011,650 |
| OWL CREEK ASSET MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 13, 2023 | 0 |
| POLAR ASSET MANAGEMENT PARTNERS INC | Beneficial Owner of more than 10% of a Class of Security | Sale | May 22, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.18% | 29,992 | 59.38K | Sep 29, 2024 |
| HRT Financial LP | 0.09% | 15,586 | 30.86K | Sep 29, 2024 |
| Vanguard Group Inc | 0.07% | 11,556 | 22.88K | Sep 29, 2024 |
| Blackrock Inc. | 0.07% | 11,908 | 23.58K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.02% | 2,814 | 5.57K | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 28 | 55 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.12% | 19,259 | 38.13K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.07% | 11,556 | 22.88K | Sep 29, 2024 |
| iShares Micro Cap ETF | 0.06% | 10,727 | 21.24K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.03% | 4,555 | 9.02K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.02% | 3,616 | 7.16K | Oct 30, 2024 |
| EQ Advisors Trust-1290 VT Micro Cap Port | 0.01% | 1,107 | 2.19K | Sep 29, 2024 |
